Business Context and Reporting Period
Company: Chicago Atlantic Real Estate Finance, Inc. (REFI)
Filing Type: Form 10-Q (Unaudited)
Period Ended: June 30, 2026
Business Overview: An externally managed mortgage REIT focused on originating senior secured loans to state-licensed cannabis operators, secured by real estate, equipment, and licenses. The Company operates as a single segment.
Key Financial Metrics
| Metric | Q2 2026 (3 Months) | YTD 2026 (6 Months) | YTD 2025 (6 Months) |
|---|---|---|---|
| Interest Income | $15.22 million | $30.38 million | $31.61 million |
| Net Interest Income | $12.83 million | $25.96 million | $27.47 million |
| Net Income | $7.47 million | $12.31 million | $18.92 million |
| Diluted EPS | $0.34 | $0.57 | $0.89 |
| Total Assets | $461.70 million (as of June 30, 2026) | ||
| Loans Held for Investment (Net) | $398.53 million (as of June 30, 2026) | ||
| Cash and Equivalents | $13.35 million (as of June 30, 2026) | ||
| Revolving Loan Outstanding | $91.05 million (as of June 30, 2026) | ||
| Notes Payable (Net) | $49.45 million (as of June 30, 2026) | ||
| Dividends Declared (YTD) | $0.94 per share |
Material Changes vs. Prior Period
- Revenue Decline: Net income decreased 35% year-over-year for the six months ended June 30, 2026, primarily due to a $4.39 million provision for current expected credit losses (CECL) compared to $0.07 million in the prior year period.
- Portfolio Yield: The weighted average yield-to-maturity (YTM) internal rate of return decreased from 16.3% at December 31, 2025, to 15.6% at June 30, 2026, driven by re-pricing amendments and a decline in the Prime rate.
- CECL Reserve Increase: The CECL reserve increased by approximately $4.3 million to $9.37 million (2.27% of principal), driven by deteriorating credit quality on specific loans (Loan #36 and non-accrual loans #4 and #34) and new originations.
- Debt Utilization: Outstanding borrowings on the Revolving Loan increased to $91.05 million from $49.10 million at year-end 2025, increasing interest expense.
Guidance, Outlook, and Material Events
- Proposed Merger: On June 17, 2026, the Company entered into a definitive merger agreement with Chicago Atlantic BDC, Inc. (LIEN). REFI will elect to be regulated as a Business Development Company (BDC) prior to the merger. The transaction is expected to close in Q4 2026, subject to stockholder and regulatory approvals.
- Subsequent Equity Issuance: On July 9, 2026, the Company issued 4.3 million shares in a private placement to Koach Capital Funds in exchange for $62.5 million in second-lien promissory notes. This transaction is treated as equity for financial reporting but as qualifying assets for REIT purposes.
- Credit Quality Concerns: Two loans (#4 and #34) remain on non-accrual status with a combined carrying value of approximately $16.5 million. Loan #36 was amended to 100% PIK interest due to payment delays, though it remains on accrual status.
- Regulatory Environment: The Company notes the April 2026 DOJ/DEA order reclassifying certain medical cannabis products from Schedule I to Schedule III, which may impact borrower cash flows and capital availability, though adult-use cannabis remains Schedule I.
- Capital Markets: The Company's previous Shelf Registration Statement expired in January 2026. A new statement has been filed but is not yet effective, suspending the At-The-Market (ATM) offering program until effectiveness is granted.
Investor Verification Checklist
- Merger Approval Status: Verify the progress of stockholder votes and regulatory approvals required for the merger with LIEN and the transition to BDC status.
- Non-Accrual Loan Resolution: Monitor the status of Loans #4 and #34 (approx. $16.5M) and the potential for further CECL reserve increases or write-offs.
- Shelf Registration Effectiveness: Confirm when the new Form S-3 registration statement becomes effective to resume equity capital raising via the ATM program.
- Interest Rate Sensitivity: Assess the impact of potential Prime rate changes on the net interest margin, given 58.8% of the portfolio is floating-rate.
- Dividend Coverage: Review Distributable Earnings ($0.90 per share YTD) relative to the declared dividend ($0.94 per share YTD) to assess sustainability.